Abstract
OBJECTIVES. Intravenous drug users are at high risk for medical illness, yet many are medically underserved. Most methadone treatment programs have insufficient resources to provide medical care. The purpose of this study was to test the efficacy of providing medical care at a methadone clinic site vs referral to another site. METHODS. Patients with any of four target medical conditions were randomized into an on-site group offered medical care at the methadone treatment clinic and a referred group offered medical care at a nearby clinic. Entry to treatment and use of medical services were analyzed. RESULTS. Of 161 intravenous drug users evaluated, 75 (47%) had one or more of the target medical conditions. Fifty-one were randomized. In the on-site group (n = 25), 92% received medical treatment; in the referred group (n = 26), only 35% received treatment. CONCLUSIONS. Providing medical care at a methadone treatment program site is more effective than the usual referral procedure and is a valuable public health intervention.
Full text
PDFSelected References
These references are in PubMed. This may not be the complete list of references from this article.
- Cooper J. R. Methadone treatment and acquired immunodeficiency syndrome. JAMA. 1989 Sep 22;262(12):1664–1668. [PubMed] [Google Scholar]
- Dans P. E., Matricciani R. M., Otter S. E., Reuland D. S. Intravenous drug abuse and one academic health center. JAMA. 1990 Jun 20;263(23):3173–3176. [PubMed] [Google Scholar]
- Drucker E. AIDS and addiction in New York City. Am J Drug Alcohol Abuse. 1986;12(1-2):165–181. doi: 10.3109/00952998609083750. [DOI] [PubMed] [Google Scholar]
- Hahn R. A., Onorato I. M., Jones T. S., Dougherty J. Prevalence of HIV infection among intravenous drug users in the United States. JAMA. 1989 May 12;261(18):2677–2684. [PubMed] [Google Scholar]
- Haverkos H. W. HIV infection among intravenous drug abusers in the United States and Europe. NIDA Res Monogr. 1988;80:7–17. [PubMed] [Google Scholar]
- Haverkos H. W., Lange W. R. From the Alcohol, Drug Abuse, and Mental Health Administration. Serious infections other than human immunodeficiency virus among intravenous drug abusers. J Infect Dis. 1990 May;161(5):894–902. doi: 10.1093/infdis/161.5.894. [DOI] [PubMed] [Google Scholar]
- Lamb R. J., Yeh I. T. Tuberculosis, AIDS, and i.v. drug abuse. N J Med. 1990 May;87(5):413–415. [PubMed] [Google Scholar]
- McGrory B. J., McDowell D. M., Muskin P. R. Medical students' attitudes toward AIDS, homosexual, and intravenous drug-abusing patients: a re-evaluation in New York City. Psychosomatics. 1990 Fall;31(4):426–433. doi: 10.1016/S0033-3182(90)72139-1. [DOI] [PubMed] [Google Scholar]
- McLellan A. T., Arndt I. O., Metzger D. S., Woody G. E., O'Brien C. P. The effects of psychosocial services in substance abuse treatment. JAMA. 1993 Apr 21;269(15):1953–1959. [PubMed] [Google Scholar]
- Mercer L. J., Robinson D. C., Sahm D. F., Lawrie M. J., Hajj S. N. Comparison of chemiluminescent DNA probe to cell culture for the screening of Chlamydia trachomatis in a gynecology clinic population. Obstet Gynecol. 1990 Jul;76(1):114–117. [PubMed] [Google Scholar]
- Schindler B. A., Blum D., Malone R. Noncompliance in the treatment of endocarditis. The medical staff as co-conspirators. Gen Hosp Psychiatry. 1988 May;10(3):197–201. doi: 10.1016/0163-8343(88)90019-9. [DOI] [PubMed] [Google Scholar]
- Selwyn P. A., Feingold A. R., Iezza A., Satyadeo M., Colley J., Torres R., Shaw J. F. Primary care for patients with human immunodeficiency virus (HIV) infection in a methadone maintenance treatment program. Ann Intern Med. 1989 Nov 1;111(9):761–763. doi: 10.7326/0003-4819-111-9-761. [DOI] [PubMed] [Google Scholar]
- Uchtenhagen A. AIDS-Epidemiologie und Prävention bei i.v.-Drogenabhängigen. Soz Praventivmed. 1988;33(7):326–330. doi: 10.1007/BF02084298. [DOI] [PubMed] [Google Scholar]